Literature DB >> 8446301

Humoral mediation of changing body composition during aging and chronic inflammation.

R Roubenoff1, L C Rall.   

Abstract

A decline in lean body mass and an accompanying increase in fat mass are known to occur during aging. The consequences of these changes in body composition may include decreased strength and physical activity, altered energy metabolism, and impaired resistance to infection. The mechanisms behind these age-related events remain unknown, but they may include changes in some of the hormonal and cytokine mediators that seem to regulate body composition. The common inflammatory condition rheumatoid arthritis could provide a useful model of these phenomena dissociated from chronological aging. This article reviews changes in neuroendocrine and immune modulators of metabolism and their consequences during aging and chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446301     DOI: 10.1111/j.1753-4887.1993.tb03045.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  14 in total

1.  Role of the renin-angiotensin system in age-related sarcopenia and diastolic dysfunction.

Authors:  Christy S Carter; Leanne Groban
Journal:  Aging health       Date:  2008-02-01

Review 2.  Rheumatoid cachexia and cardiovascular disease.

Authors:  Gregory D Summers; Giorgos S Metsios; Antonios Stavropoulos-Kalinoglou; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2010-07-20       Impact factor: 20.543

Review 3.  Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD.

Authors:  Bruno-Pierre Dubé; Pierantonio Laveneziana
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

4.  Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment.

Authors:  K Briot; P Garnero; A Le Henanff; M Dougados; C Roux
Journal:  Ann Rheum Dis       Date:  2005-01-07       Impact factor: 19.103

5.  A close association of body cell mass loss with disease activity and disability in Chinese patients with rheumatoid arthritis.

Authors:  Yi-Ming Chen; Hsin-Hua Chen; Chia-Wei Hsieh; Tsu-Yi Hsieh; Joung-Liang Lan; Der-Yuan Chen
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

6.  Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study.

Authors:  Ann-Charlotte Elkan; Niclas Håkansson; Johan Frostegård; Tommy Cederholm; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2009-03-10       Impact factor: 5.156

7.  Cystatin C and aging success.

Authors:  Mark J Sarnak; Ronit Katz; Linda F Fried; David Siscovick; Brian Kestenbaum; Stephen Seliger; Dena Rifkin; Russell Tracy; Anne B Newman; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2008-01-28

Review 8.  Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.

Authors:  Rosario Peluso; Giovanni Cafaro; Alessandro Di Minno; Salvatore Iervolino; Pasquale Ambrosino; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 3.650

9.  Antiarthritic effect of aqueous and ethanolic leaf extracts of Pistia stratiotes in adjuvant-induced arthritis in Sprague-Dawley rats.

Authors:  Samuel Kyei; George A Koffuor; Johnson N Boampong
Journal:  J Exp Pharmacol       Date:  2012-03-20

10.  Association of Frailty based on self-reported physical function with directly measured kidney function and mortality.

Authors:  Cynthia Delgado; Barbara A Grimes; David V Glidden; Michael Shlipak; Mark J Sarnak; Kirsten L Johansen
Journal:  BMC Nephrol       Date:  2015-12-09       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.